Wang Mingyao, Cheng Guang, Villalta Peter W, Hecht Stephen S
University of Minnesota Cancer Center, MMC 806, 420 Delaware Street Southeast, Minneapolis, MN 55455, USA.
Chem Res Toxicol. 2007 Aug;20(8):1141-8. doi: 10.1021/tx700189c. Epub 2007 Aug 4.
Reaction of formaldehyde with DNA in vitro produces a variety of adducts among which are observed the cross-link di-(N(6)-deoxyadenosyl)methane (dAdo-CH 2-dAdo, 1) and the hydroxymethyl adduct N(6)-hydroxymethyl-dAdo (N(6)-HOCH 2-dAdo, 2). While the structures of these adducts have been known for decades, there have been no reports of their formation in vivo. Formaldehyde is released during intracellular metabolism of carcinogenic N-nitrosomethyl compounds such as N-nitrosodimethylamine (NDMA) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), but DNA adducts formed by this pathway have not been previously characterized. In this study, we addressed these questions by developing highly sensitive liquid chromatography-electrospray ionization-tandem mass spectrometry-selected reaction monitoring methods for quantitation of adducts 1 and 2, the latter as N(6)-methyl-dAdo ( 3). Considerable effort was devoted to the problem of artifactual formation of 1, which can occur during storage of DNA samples by reaction of dAdo with 2. This problem was solved by the addition of adenosine deaminase during the DNA hydrolysis step, thus removing dAdo as a reactant. The instability of adduct 2 was another potential block to analysis, and this was solved by converting it to 3 with NaBH 3CN. Separate aliquots of DNA were analyzed for adducts 1 and 2, using the [(15)N]-labeled adducts as internal standards. The application of these methods to rat hepatic DNA to which adducts 1 and 3 were added demonstrated accuracy and precision. The detection limits for adducts 1 and 3 were 1-4 adducts per 10 (9) nucleotides using 100-150 microg of DNA. The method was applied to analyze hepatic and pulmonary DNA from rats treated with NDMA and NNK. The results clearly demonstrated the dose-dependent presence of N(6)-HOCH 2-dAdo ( 2) in all DNA samples. The cross-link adduct dAdo-CH 2-dAdo ( 1) was observed in hepatic DNA of NNK-treated rats, with lower amounts in pulmonary DNA. Levels of these adducts were generally less than those of DNA adducts formed by the classical diazohydroxide pathway of nitrosamine metabolism. The results of this study demonstrate for the first time the presence of formaldehyde DNA adducts in tissues of rats treated with carcinogenic nitrosamines and suggest that these adducts may play a role in cancer induction by these compounds.
甲醛与DNA在体外反应会产生多种加合物,其中可观察到交联二聚体(N(6)-脱氧腺苷基)甲烷(dAdo-CH₂-dAdo,1)和羟甲基加合物N(6)-羟甲基-dAdo(N(6)-HOCH₂-dAdo,2)。虽然这些加合物的结构已为人所知数十年,但尚无关于它们在体内形成的报道。甲醛在致癌性N-亚硝基甲基化合物如N-亚硝基二甲胺(NDMA)和4-(甲基亚硝基氨基)-1-(3-吡啶基)-1-丁酮(NNK)的细胞内代谢过程中释放,但此前尚未对通过该途径形成的DNA加合物进行表征。在本研究中,我们通过开发高灵敏度液相色谱-电喷雾电离-串联质谱-选择反应监测方法来定量加合物1和2(后者以N(6)-甲基-dAdo(3)的形式),解决了这些问题。我们投入了大量精力解决加合物1的人为形成问题,该问题可能在DNA样品储存过程中由dAdo与2反应产生。通过在DNA水解步骤中添加腺苷脱氨酶解决了这个问题,从而去除了作为反应物的dAdo。加合物2的不稳定性是分析的另一个潜在障碍,通过用NaBH₃CN将其转化为3解决了这个问题。使用[(¹⁵)N]标记的加合物作为内标,对DNA的不同等分试样分析加合物1和2。将这些方法应用于添加了加合物1和3的大鼠肝脏DNA,证明了其准确性和精密度。使用100 - 150微克DNA时,加合物1和3的检测限为每10⁹个核苷酸1 - 4个加合物。该方法用于分析用NDMA和NNK处理的大鼠的肝脏和肺部DNA。结果清楚地表明,在所有DNA样品中均存在剂量依赖性的N(6)-HOCH₂-dAdo(2)。在NNK处理的大鼠肝脏DNA中观察到交联加合物dAdo-CH₂-dAdo(1),在肺部DNA中的含量较低。这些加合物的水平通常低于通过亚硝胺代谢的经典重氮氧化物途径形成的DNA加合物。本研究结果首次证明了在用致癌性亚硝胺处理的大鼠组织中存在甲醛DNA加合物,并表明这些加合物可能在这些化合物诱导癌症中起作用。